275 related articles for article (PubMed ID: 35988663)
1. Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020.
Geusau A; Chromy D; Heissenberger D; Lippert K; Eder C; Heger F; Indra A; Willinger B; Pleininger S
Int J Antimicrob Agents; 2022; 60(5-6):106656. PubMed ID: 35988663
[TBL] [Abstract][Full Text] [Related]
2. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
Nokchan N; Wongsurawat T; Jenjaroenpun P; Nitayanon P; Tribuddharat C
PLoS One; 2022; 17(7):e0271657. PubMed ID: 35905043
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and genotypic characterization of
Jünger C; Imkamp F; Balakrishna S; Gysin M; Haldimann K; Brugger SD; Scheier TC; Hampel B; Hobbie SN; Günthard HF; Braun DL
Int J STD AIDS; 2024 May; 35(6):462-470. PubMed ID: 38297880
[TBL] [Abstract][Full Text] [Related]
5. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
6. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of 1710 surveillance-based
Reimche JL; Clemons AA; Chivukula VL; Joseph SJ; Schmerer MW; Pham CD; Schlanger K; St Cyr SB; Kersh EN; Gernert KM; Antimicrobial-Resistant Working Group
Microb Genom; 2023 May; 9(5):. PubMed ID: 37171855
[TBL] [Abstract][Full Text] [Related]
8. Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.
Demczuk W; Martin I; Sawatzky P; Allen V; Lefebvre B; Hoang L; Naidu P; Minion J; VanCaeseele P; Haldane D; Eyre DW; Mulvey MR
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871081
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
[TBL] [Abstract][Full Text] [Related]
10. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
Peters RPH; Jung H; Mitchev N; Mdingi MM; Gigi R; Shroufi A; Martinez FP; Bamford C
Sex Transm Dis; 2023 Dec; 50(12):821-826. PubMed ID: 37820114
[TBL] [Abstract][Full Text] [Related]
12. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
[TBL] [Abstract][Full Text] [Related]
13. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
[TBL] [Abstract][Full Text] [Related]
14. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
[TBL] [Abstract][Full Text] [Related]
15. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
Ryan L; Golparian D; Fennelly N; Rose L; Walsh P; Lawlor B; Mac Aogáin M; Unemo M; Crowley B
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1661-1672. PubMed ID: 29882175
[TBL] [Abstract][Full Text] [Related]
17. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
Katz AR; Komeya AY; Kirkcaldy RD; Whelen AC; Soge OO; Papp JR; Kersh EN; Wasserman GM; O'Connor NP; O'Brien PS; Sato DT; Maningas EV; Kunimoto GY; Tomas JE
Clin Infect Dis; 2017 Sep; 65(6):918-923. PubMed ID: 28549097
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Shimuta K; Unemo M; Nakayama S; Morita-Ishihara T; Dorin M; Kawahata T; Ohnishi M;
Antimicrob Agents Chemother; 2013 Nov; 57(11):5225-32. PubMed ID: 23939890
[TBL] [Abstract][Full Text] [Related]
20. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
